← Eichor
Study identifier: NCT07090161 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

Condition: Hypertension · Uncontrolled Hypertension  ·  Sponsor: Vanda Pharmaceuticals

PhasePhase 2
Planned participants240
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension

This description comes directly from the study's public registry record.

Talk to the study team

Vanda Pharmaceuticals, Inc.  ·  202-734-3400  ·  clinicaltrials@vandapharma.com

Always discuss trial participation with your own doctor first.

Locations (28)

Vanda Investigative SitePhoenix, Arizona, United StatesNot Yet Recruiting
Vanda Investigative SiteTempe, Arizona, United StatesRecruiting
Vanda Investigative SiteTucson, Arizona, United StatesNot Yet Recruiting
Vanda Investigative SiteChula Vista, California, United StatesRecruiting
Vanda Investigative SiteDublin, California, United StatesRecruiting
Vanda Investigative SiteValencia, California, United StatesNot Yet Recruiting
Vanda Investigative SiteWalnut Creek, California, United StatesRecruiting
Vanda Investigative SiteDoral, Florida, United StatesNot Yet Recruiting
Vanda Investigative SiteFort Myers, Florida, United StatesRecruiting
Vanda Investigative SiteColumbus, Georgia, United StatesRecruiting
Vanda Investigative SiteOak Brook, Illinois, United StatesRecruiting
Vanda Investigative SiteTinley Park, Illinois, United StatesRecruiting

+ 16 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07090161